Tenatumomab (Anti-Tenascin C) is a murine monoclonal antibody targeting tenascin-C. It has been used for Pretargeted Antibody Guided Radioimmunoresearch (PAGRIT), and delivering radionuclides to tumors via PAGRIT and direct 131Iodine labeling approach. MW :146.48 KD.